1,347
Views
4
CrossRef citations to date
0
Altmetric
Review

Use of adjuvanted trivalent influenza vaccine in older-age adults: a systematic review of economic evidence

ORCID Icon, , & ORCID Icon
Pages 1035-1047 | Received 15 Nov 2018, Accepted 30 Jan 2019, Published online: 25 Mar 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ke Zhang, Xiaoxue Wu, Yu Shi, Xiaoqin Gou & Junqiong Huang. (2021) Immunogenicity of H5N1 influenza vaccines in elderly adults: a systematic review and meta-analysis. Human Vaccines & Immunotherapeutics 17:2, pages 475-484.
Read now

Articles from other publishers (3)

Maarten Postma, David Fisman, Norberto Giglio, Sergio Márquez-Peláez, Van Hung Nguyen, Andrea Pugliese, Jesús Ruiz-Aragón, Analia Urueña & Joaquin Mould-Quevedo. (2023) Real-World Evidence in Cost-Effectiveness Analysis of Enhanced Influenza Vaccines in Adults ≥ 65 Years of Age: Literature Review and Expert Opinion. Vaccines 11:6, pages 1089.
Crossref
Michele A. Kohli, Michael Maschio, Shannon Cartier, Joaquin Mould-Quevedo & Frank-Ulrich Fricke. (2022) The Cost-Effectiveness of Vaccination of Older Adults with an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Other Available Quadrivalent Vaccines in Germany. Vaccines 10:9, pages 1386.
Crossref
Tanja Fens, Pieter T. de Boer, Eugène P. van Puijenbroek & Maarten J. Postma. (2021) Inclusion of Safety-Related Issues in Economic Evaluations for Seasonal Influenza Vaccines: A Systematic Review. Vaccines 9:2, pages 111.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.